Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
5 c » 25 c (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
5 c » 25 c (Expand Search)
-
1
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
-
2
Rcan2-mediated decrease in intracellular K<sup>+</sup> involves Kcnk5b.
Published 2024Subjects: “…observed coordinated decreases…”
-
3
PI+ CD3+ T cells decrease at day 14 after IR while PI+ CD3- cells decrease at all time points.
Published 2024Subjects: -
4
-
5
-
6
-
7
mGluR5 receptor decreased glycinergic currents.
Published 2019“…The original traces were taken at the time points indicated by the numbers 1–3. (<b>C</b>) The inhibitory effect of DHPG on GlyR-IPSCs was blocked by MPEP (92.4 ± 4.4% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 1.573, <i>p</i> = 0.177) but not by CPCCOEt (53.5 ± 3.7% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 14.343, <i>p</i> < 0.001). …”
-
8
Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR.
Published 2024Subjects: -
9
-
10
-
11
-
12
-
13
Chemokines, with the exception of CXCL1 and MCP-1, decrease acutely following 5 Gy IR.
Published 2024Subjects: -
14
Inclusion of SRRM4-regulated exons is decreased in tumors and cancer cell lines.
Published 2021“…(B) SRRM4 target exons with respect to their average PSI in normal tissues. Red points are exons with PSI decreasing by at least 5% in at least 1 tumor type. …”
-
15
-
16
-
17
-
18
Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice.
Published 2022Subjects: -
19
-
20